Ambutung, Narcesa A.

HRN: 23-65-53  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/06/2023
CEFUROXIME 750MG (VIAL)
09/06/2023
09/12/2023
IVT
750mg
Q8
Fracture P3rd Femur R; T/c Cerebral Concussion Sec To Fall
09/15/2023
CO-AMOXICLAV 625MG (TAB)
09/15/2023
09/22/2023
ORAL
625mg
TID
Femoral Fracture R; T/C Cerebrql Concussion
Waiting Final Action 
09/20/2023
CEFTRIAXONE 1G (VIAL)
09/20/2023
09/27/2023
IV
2g
Q 12H
S/P OR IM Nailing, R Femur
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: